Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
about
Dopaminergic substitution in Parkinson's disease.Paradoxical aspects of parkinsonian tremor.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective.Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.
P2860
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Budipine provides additional b ...... mum dopaminergic drug regimen.
@ast
Budipine provides additional b ...... mum dopaminergic drug regimen.
@en
Budipine provides additional b ...... mum dopaminergic drug regimen.
@nl
type
label
Budipine provides additional b ...... mum dopaminergic drug regimen.
@ast
Budipine provides additional b ...... mum dopaminergic drug regimen.
@en
Budipine provides additional b ...... mum dopaminergic drug regimen.
@nl
prefLabel
Budipine provides additional b ...... mum dopaminergic drug regimen.
@ast
Budipine provides additional b ...... mum dopaminergic drug regimen.
@en
Budipine provides additional b ...... mum dopaminergic drug regimen.
@nl
P2093
P1433
P1476
Budipine provides additional b ...... mum dopaminergic drug regimen.
@en
P2093
Bernhard Rathay
Dieter Müller
Dieter Volc
Elemer Teshmar
Gerd Fuchs
Gudrun Ulm
Harald Bliesath
Harald Haller
Horst Przuntek
Joachim Glass
P304
P356
10.1001/ARCHNEUR.59.5.803
P577
2002-05-01T00:00:00Z